Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission*
暂无分享,去创建一个
F. Veglia | M. De Metrio | G. Marenzi | A. Bartorelli | P. Montorsi | J. Campodonico | M. Moltrasio | G. Lauri | M. Rubino | I. Marana | E. Assanelli
[1] Adnan Kastrati,et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.
[2] R. Ceriani,et al. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial* , 2008, Critical care medicine.
[3] C. Macaya,et al. Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: related factors. , 2007, International journal of cardiology.
[4] M. Pfisterer,et al. Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial. , 2007, Chest.
[5] G. Schuler,et al. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. , 2007, European heart journal.
[6] Heather Prouty. Trends in Acute Myocardial Infarction Complicated by Cardiogenic Shock, 1979–2003, United States , 2007 .
[7] K. Nakao,et al. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. , 2007, Kidney international.
[8] R. Bellomo,et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients* , 2007, Critical care medicine.
[9] J. Kaski,et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. , 2007, Journal of the American College of Cardiology.
[10] B. Brodie,et al. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. , 2007, The American journal of cardiology.
[11] G. Mensah,et al. Trends in acute myocardial infarction complicated by cardiogenic shock, 1979-2003, United States. , 2006, American heart journal.
[12] G. Parodi,et al. Routine percutaneous coronary intervention in elderly patients with cardiogenic shock complicating acute myocardial infarction. , 2006, American heart journal.
[13] F. Veglia,et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. , 2006, The New England journal of medicine.
[14] J. Hochman,et al. Echocardiographic and angiographic correlations in patients with cardiogenic shock secondary to acute myocardial infarction. , 2006, The American journal of cardiology.
[15] D. Burkhoff,et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. , 2006, American heart journal.
[16] K. Huber,et al. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction* , 2006, Critical care medicine.
[17] F. Veglia,et al. N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty , 2006 .
[18] H. White,et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. , 2006, JAMA.
[19] R. Fernandez,et al. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. , 2005, JAMA.
[20] John A Kellum,et al. Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.
[21] A. Zangrillo,et al. Renoprotective Action of Fenoldopam in High-Risk Patients Undergoing Cardiac Surgery: A Prospective, Double-Blind, Randomized Clinical Trial , 2005, Circulation.
[22] Arthur S Slutsky,et al. Mechanical ventilation and acute renal failure* , 2005, Critical care medicine.
[23] G. Schuler,et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. , 2003, European heart journal.
[24] A. Kribben,et al. Early detection of acute renal failure by serum cystatin C. , 2004, Kidney international.
[25] T. LeJemtel,et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. , 2004, Journal of the American College of Cardiology.
[26] R. Bellomo,et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.
[27] G. Marenzi,et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.
[28] G. Marenzi,et al. Continuous veno‐venous hemofiltration for the treatment of contrast‐induced acute renal failure after percutaneous coronary interventions , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[29] E. Falk,et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003, European heart journal.
[30] G. Karth,et al. Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. , 2002, The American journal of medicine.
[31] P. Agostoni,et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. , 2001, Journal of the American College of Cardiology.
[32] G. Dangas,et al. Acute renal failure requiring dialysis after percutaneous coronary interventions , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[33] R. Bellomo,et al. Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. , 2001, The Annals of thoracic surgery.
[34] H. White,et al. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry☆ , 2000 .
[35] R. Lange,et al. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? , 2000, Journal of the American College of Cardiology.
[36] U. Janssens,et al. Evaluation of the SOFA score: a single-center experience of a medical intensive care unit in 303 consecutive patients with predominantly cardiovascular disorders , 2000, Intensive Care Medicine.
[37] Arthur S Slutsky,et al. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. , 2000, JAMA.
[38] H. S,et al. Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock , 2000 .
[39] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[40] T. Scalea,et al. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late , 1999, Intensive Care Medicine.
[41] R. Califf,et al. Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. , 1999, American heart journal.
[42] J. Gurwitz,et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. , 1999, The New England journal of medicine.
[43] R. Califf,et al. One-year survival among patients with acute myocardial infarction complicated by cardiogenic shock, and its relation to early revascularization: results from the GUSTO-I trial. , 1999, Circulation.
[44] Arthur S Slutsky,et al. Multiple system organ failure. Is mechanical ventilation a contributing factor? , 1998, American journal of respiratory and critical care medicine.
[45] Paul Landais,et al. Acute renal failure in intensive care units : causes, outcome, and prognostic factors of hospital mortality : a prospective, multicenter study , 1996 .
[46] M. Gotsman,et al. Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. , 1993, European heart journal.